DNA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ginkgo Bioworks Holdings Inc

Watchlist Manager

Watchlist

Price: 7.89 USD -1.38% Market Closed

Market Cap: $491.7m

	Ginkgo Bioworks Holdings Inc NYSE:DNA	US
	Samsung Electro-Mechanics Co Ltd KRX:009150	KR
	CF Industries Holdings Inc NYSE:CF	US
M	MBC Group CJSC SAU:4072	SA
R	Royal Holdings Co Ltd TSE:8179	JP
	Aura Biosciences Inc NASDAQ:AURA	US
	Sectra AB F:61L0	SE
O	OM2 Network Co Ltd TSE:7614	JP
	Booking Holdings Inc NASDAQ:BKNG	US

Profitability Summary

Ginkgo Bioworks Holdings Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

72%

Strong 3Y Average Gross Margin

77%

Gross Margin is Increasing

64% > 72%

Negative Operating Margin

-182%

Negative 3Y Average Operating Margin

-223%

Operating Margin is Increasing

-433% > -182%

Negative Net Margin

-184%

Negative 3Y Average Net Margin

-286%

Net Margin is Increasing

-441% > -184%

Negative Free Cash Flow Margin

-105%

Negative 3Y Average Free Cash Flow Margin

-140%

Declining Free Cash Flow Margin

-100% > -105%

Negative ROE

-51%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-62%

ROIC is Increasing

-195% > -42%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.